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Vertical transMission of HiV
Is elimination of vertical transmission of HIV in 
high prevalence settings achievable?
Ameena Goga and colleagues argue that more realistic targets are needed to maintain 
momentum on reducing vertical transmission in countries with a high HIV prevalence
The idea of eliminating infectious diseases from society dates to the 18th century, when Edward Jenner envisioned elimination of smallpox through widespread 
vaccination. By 1997, the difference 
between control, eradication, and elimi-
nation had been defined (box 1).1 2 Of the 
perinatally acquired infections, only teta-
nus, HIV, and syphilis have been targeted 
for elimination.3 4
In 2011, the joint United Nations 
Programme on HIV/AIDS (UNAIDS) 
launched a global plan to eliminate new 
HIV infections among children by 2015 
and to keep mothers with HIV infection 
alive.5 This prioritised elimination of 
vertical transmission of HIV (also known 
as mother-to-child transmission of HIV) in 
the 22 countries where 90% of the world’s 
pregnant women with HIV reside (global 
plan priority countries).5 UNAIDS reported 
in 2016 that 1.2 million new HIV infections 
in children were averted in the 21 global 
plan priority countries in sub-Saharan 
Africa between 2009 and 2015.6 Seven 
of these countries had reduced new HIV 
infections by more than 70% since 2009 
(Burundi 84%, Malawi 71%, Mozambique 
75%, Namibia 79%, South Africa 84%, 
and Swaziland 80%).6 UNAIDS highlighted 
the urgent need for action to end the AIDS 
epidemic by 2030 as part of the sustainable 
development goals. 
What is meant by eliminating HIV?
In 2012, a global consultation of over 70 
experts, including country programme 
managers, agreed that one of the criteria 
to validate elimination of vertical trans-
mission of HIV as a public health problem 
is a paediatric HIV incidence of ≤50 cases 
per 100 000 live births (box 2).4 This pae-
diatric case rate was chosen because it was 
consistent with previous WHO elimination 
initiatives and expert consensus was that it 
was achievable (personal communication, 
C Hayashi, Unicef).
The decision to focus on eliminating 
rather than eradicating vertical transmission 
was taken because optimal interventions 
to prevent vertical HIV transmission 
are not 100% effective. Eliminating a 
disease as a public health problem is a 
powerful motivator and one that can be 
embraced without overpromising or setting 
programmes up for failure.
In 2014, the WHO published criteria 
to validate that a country has eliminated 
vertical transmission of HIV (box 2).4 
The WHO guidance, updated in 2017, 
recommends that each country should 
have adequate national monitoring and 
evaluation systems in place and adequate 
laboratory systems within the public and 
private sectors to assist with measurement.7
As of October 2017, the 10 countries or 
territories where elimination of vertical 
transmission of HIV has been validated are 
Cuba, Thailand, Armenia, Belarus, Anguilla, 
Montserrat, Cayman Islands, Bermuda, 
Antigua and Barbuda, and St Kitts and 
Nevis.7-10 However, none of these countries 
has a high HIV prevalence and none is a 
global plan priority country. In 2017, the 
concept of pre-elimination was introduced 
to recognise progress in preventing vertical 
transmission of HIV in high burden 
countries.11 To achieve validation for pre-
elimination, ≥90% coverage across all 
three process indicator targets is needed 
and the rate of vertical transmission must 
be below 5%. Importantly, there is no new 
target transmission case rate to qualify for 
pre-elimination. The complexity of vertical 
transmission of HIV means that achieving 
the child case rate to validate elimination 
will continue to be challenging in priority 
countries. Here we suggest how interest in 
the aspirational goal of eliminating vertical 
transmission of HIV can be maintained 
even though the case rate target seems 
unattainable in the short to medium term.
What makes eliminating vertical transmission 
so complex?
A comparison with neonatal tetanus, one 
of the three neonatal diseases targeted for 
elimination, shows the complexity of elim-
inating vertical transmission of HIV (see 
supplementary table on bmj.com). Neona-
tal tetanus is a non-transmissible disease 
caused by Clostridium tetani, a ubiquitous 
neurotoxin producing bacterium that con-
taminates infants’ umbilical cords through 
Key messages
•   An HIV infection case rate of ≤50/100 
000 live births is needed to validate a 
country’s elimination of vertical trans-
mission as a public health problem
•   The case rate heavily depends on 
maternal HIV prevalence, making 
elimination targets challenging in 
high prevalence settings even with 
low vertical transmission rates
•   The case rate is an aspirational goal 
that may not be realised in the short 
to medium term in many high HIV 
prevalence settings
•   To maintain momentum, policy 
makers should identify and monitor 
process indicators that increase oppor-
tunities for HIV prevention
Box 1: Definitions of disease elimination
•	Control—The reduction of disease incidence, prevalence, morbidity, or mortality to a locally 
acceptable level as a result of deliberate efforts. Continued intervention measures are 
required to maintain the reduction (eg, diarrhoeal disease)
•	Elimination	of	disease—Reduction of a specified disease to zero incidence in a defined 
geographical area as a result of deliberate efforts. Continued intervention measures are 
required (eg, neonatal tetanus)
•	Elimination	of	infections—Reduction to zero incidence of infection caused by a specific agent 
in a defined geographical area as a result of deliberate efforts. Continued measures are 
needed to prevent re-establishment of transmission (eg, measles, polio)
•	Eradication—Permanent zero worldwide incidence of infections with a specific agent as a 
result of deliberate efforts. Intervention measures are no longer needed (eg, smallpox)
•	Extinction—The specific agent no longer exists in nature or in the laboratory
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unhygienic delivery practices. Neonatal tet-
anus progresses quickly and can take 3–21 
days between infection and the appearance 
of disease. In contrast, children mainly 
acquire HIV infection from their moth-
ers during pregnancy, labour, delivery, or 
breastfeeding. HIV may not be detectable 
for up to six weeks after infection, and it 
can take months to progress to AIDS.
C tetani bacteria are transmitted by 
a single route, which does not depend 
on maternal infection or drug therapy. 
Consequently, neonatal tetanus is easily 
prevented by immunising women during 
pregnancy alongside hygienic delivery 
practices and proper cord care to prevent 
cord contamination.3 Preventing vertical 
transmission of HIV is more complex, 
requiring intervention from preconception 
to the end of breastfeeding. This includes 
primary prevention of HIV before, during, 
and after pregnancy; prevention of 
unwanted or unplanned pregnancies; early 
initiation of antiretroviral therapy (ART); 
retention on ART for women with HIV; and 
retesting women without HIV to detect 
new infections early. Early antenatal care 
is also important to optimise general care, 
monitoring of maternal viral load, safe 
delivery practices, and infant postexposure 
prophylaxis.12-15
What makes the target case rate hard to 
achieve?
Despite the complexity of reducing vertical 
transmission, many countries with a high 
HIV prevalence have made good progress. 
However, they remain far from achieving 
a case rate of ≤50 new HIV infections per 
100 000 live births at the end of breastfeed-
ing, which is needed to validate elimination 
of vertical transmission.6 One reason for 
this it that the case rate for new child infec-
tions depends on maternal HIV prevalence 
as well as the vertical transmission rate. In 
settings where maternal HIV prevalence is 
high it can be very hard to attain the target 
case rate even when the vertical transmis-
sion rate is low (box 3).
To achieve a case rate of ≤50/100 000 
live births when maternal HIV prevalence 
is 5%, the vertical transmission rate needs 
to be 1% (fig 1). As long as maternal HIV 
prevalence is ≥10% the target case rate 
cannot be achieved, even if the vertical 
transmission rate is reduced to 1%. Given 
the high prevalence of maternal HIV in 
the priority countries (roughly 30% in 
South Africa, for example17) our sensitivity 
analysis raises questions around the 
usefulness of focusing on achieving 
the child case rate in the short term. In 
addition, we believe the gap between the 
current and target case rate is dampening 
the enthusiasm of funders, policy makers, 
managers, and frontline service providers 
because they know how far they are from 
the target.
Maintaining momentum in the elimination 
agenda
Given the substantial challenges in reach-
ing the case rate target to achieve valida-
tion for elimination of vertical transmission 
of HIV, we suggest a greater focus on and 
recognition of process targets to maintain 
momentum. Policy makers and managers 
could track additional process indicators 
that increase opportunities for HIV pre-
vention during the pre-elimination period. 
These can be tracked locally, regionally, 
and nationally through quality improve-
ment processes that have been shown to 
be effective in routine settings.18
Data dashboards that track vertical 
transmission of HIV indicators have been 
associated with improved programme 
performance at national and facility 
levels.18 19 These dashboards use red, 
amber, and green colour coding to illustrate 
achievement of targets. We suggest that 
policy makers or managers issue annual or 
biennial recognition for selected indicator 
measurements in relation to global goals. 
These selected indicators could be expanded 
beyond the current pre-elimination list 
to include those that measure increased 
coverage and uptake of maternal and 
child healthcare, on the assumption 
that increased coverage will reduce 
Box 2: Criteria for elimination of vertical HIV transmission
Impact criteria (to be sustained for one year)
•	Vertical transmission of HIV in breastfed population <5% (number of HIV infected children 
divided by number of HIV exposed children tested for HIV at the end of breastfeeding)
•	≤50 new child HIV infections per 100 000 live births (case rate)
Process criteria (to be sustained for two years)
•	Antenatal care coverage among all pregnant women ≥95%
•	HIV testing coverage among all pregnant women ≥95%
•	Antiretroviral treatment coverage for pregnant women with HIV infection ≥95%
[1] All criteria have to be met for WHO to recognise elimination
Box 3: Discord between vertical 
transmission and target case rates10
In 2016–17, antenatal HIV prevalence 
in South Africa was roughly 32% and the 
national intrauterine vertical transmission 
of HIV rate was 0.9% at delivery. This 
corresponds to a HIV case rate at delivery of 
288/100 000 live births (32% multiplied by 
100 000 live births (to calculate number of 
babies exposed to HIV) multiplied by 0.9%). 
This value is well above the target of ≤50 
babies and is a measure of intrauterine HIV 
transmission, not transmission at the end of 
breastfeeding.16
At the provincial level, across South 
Africa, intrauterine vertical transmission 
rates ranged from 0.6% to 1.3%, but 
new HIV infection case rates ranged from 
168/100 000 to 325/100 000 live births.16
UNAIDS 2017 models estimate that vertical 
transmission rates range from 4% (Namibia 
and Uganda) to 21% (Angola) in the 22 
global plan priority countries but case rates 
range from 85/100 000 live births in Burundi 
to >2000/100 000 in Swaziland.
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Fig 1 | Sensitivity analysis of child case rates, maternal HIV prevalence, and vertical 
transmission rate
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missed opportunities to prevent vertical 
transmission of HIV (box 4). We suggest six 
colour coded levels for recognition against 
global goals: red (0–25% coverage), blue 
(>25–50% coverage), bronze (>50–75% 
coverage), silver (>75–89% coverage), gold 
(90–94%), and platinum (>94% coverage). 
These suggested cut-offs are based on 
quartiles, with the upper quartile split to 
reflect the pre-elimination and elimination 
criteria set out in WHO guidance.
This system could help maintain 
momentum by providing achievable targets 
towards eliminating vertical HIV infection. 
It could also be used to identify gaps with 
monitoring and attainment of targets and 
to guide the development of interventions 
to address these gaps.
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Box 4: Potential indicators to track progress in eliminating vertical transmission
•	% coverage for family planning (among all women)
•	% pregnant women booking antenatal appointments before 12 weeks’ gestation
•	% pregnant women attending at least eight antenatal visits
•	% HIV testing coverage among pregnant women
•	% pregnant women having institutional deliveries
•	% HIV re-testing coverage among pregnant women without HIV at delivery
•	% ART coverage among pregnant or breastfeeding women with HIV
•	% viral suppression among pregnant or breastfeeding women with HIV taking ART
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